Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06980376

Milk Free From A1-Type β-Casein on Inflammation, Gastrointestinal Tolerance, and Pregnancy Outcomes

Effects of Milk Free From A1-Type β-Casein on Inflammation, Gastrointestinal Tolerance, and Pregnancy Outcomes: A Multi-Centre, Randomised, Open-Label, Prospective Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
a2 Milk Company Ltd. · Industry
Sex
Female
Age
20 Years – 35 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to compare the effects of conventional Ultra High Temperature (UHT) milk containing both A1 and A2 type β-caseins (CON) with a2 UHT Milk containing A2 type β-casein only (A1PF) on inflammation, tolerance, and GI symptoms in pregnant women as well as infants' birth outcomes from 12 weeks' gestation up to 40 days post-birth.

Conditions

Interventions

TypeNameDescription
OTHERa2 UHT milkPregnant women in this arm will drink a2 UHT Milk twice a day, 200ml each time, until study completion. Their infants will be fed with the mother's breastmilk exclusively.
OTHERConventional UHT MilkPregnant women in this arm will drink conventional UHT Milk twice a day, 200ml each time, until study completion. Their infants will be fed with the mother's breastmilk exclusively.

Timeline

Start date
2025-08-25
Primary completion
2026-09-01
Completion
2026-09-01
First posted
2025-05-20
Last updated
2026-02-06

Locations

6 sites across 1 country: China

Source: ClinicalTrials.gov record NCT06980376. Inclusion in this directory is not an endorsement.